Biotech

All Articles

Lykos 'remorses' not making known research offenses with publisher

.Psychopharmacology has actually drawn three write-ups about midstage professional test information ...

Analysts go into Avidity's DMD succeed, exposing nuances in data

.Avidity Biosciences impressed clients along with stage 1/2 information in Duchenne muscular dystrop...

Actinogen's cortisol blocker fails period 2 clinical depression research

.Actinogen Medical's cortisol blocker has actually missed out on the major endpoint of a period 2 st...

Bivictrix makes a decision going private only method to take ADC right into facility

.Antibody-drug conjugates (ADCs) have gone to the center of many a billion-dollar biobuck licensing ...

TPG bests up funds to $580M for investments across life sciences

.Property supervisor TPG, which has actually assisted biotechs like Sionna Rehabs and Santa Clam Ana...

Merck quits stage 3 TIGIT trial in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT plan has actually endured an additional setback. Months after shuttering a s...

After a difficult year, Exscientia folds in to Recursion

.After a year defined through pipeline cuts, the shift of its chief executive officer and also layof...

Cullinan, after $25M package, hands back bispecific to Port

.Cullinan Therapy was actually thrilled enough with Harbour BioMed's bispecific invulnerable reactor...

A nearer check out Fierce Biotech's Ferocious 15

.In this particular full week's episode of "The Leading Line," our company're diving right into Fier...

Lilly encounters phase 2 failure of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's event celebrating the approval of Alz...